Xenon Pharmaceuticals (XENE) Other Non Operating Income (2013 - 2026)
Xenon Pharmaceuticals (XENE) posted quarterly Other Non Operating Income of $548000.0 for Q1 2026, up 1465.71% year-over-year from $35000.0 in Q1 2025, and up 285.14% quarter-over-quarter from -$296000.0 in Q4 2025.
Powered by 
Analysis
Xenon Pharmaceuticals (XENE) Other Non Operating Income (2013 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Other Non Operating Income for 14 consecutive years, with $548000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income rose 1465.71% year-over-year to $548000.0; the TTM figure through Mar 2026 stood at $1.9 million (up 255.6% YoY), while the FY2025 annual figure was $1.3 million, up 226.69% from the prior year.
- Other Non Operating Income advanced to $548000.0 in Q1 2026 per XENE's latest filing, from -$296000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.7 million in Q2 2025 and bottomed at -$2.4 million in Q3 2022.
- Historically, Other Non Operating Income has averaged -$50588.2 across 5 years, with a median of $35000.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Non Operating Income sank 1760.16% — and 2025, when it jumped 16880.0%.
- Xenon Pharmaceuticals' Other Non Operating Income stood at $602000.0 in 2022, then plunged by 114.95% to -$90000.0 in 2023, then tumbled by 1542.22% to -$1.5 million in 2024, then soared by 79.97% to -$296000.0 in 2025, then soared by 285.14% to $548000.0 in 2026.
- Business Quant data shows XENE's Other Non Operating Income at $548000.0 in Q1 2026, -$296000.0 in Q4 2025, and -$89000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Xenon Pharmaceuticals | 5.93 Bn | 5.93 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -311,000.00 |
| Mar 31, 2026 | 548,000.00 |
| Dec 31, 2025 | -296,000.00 |
| Sep 30, 2025 | -89,000.00 |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | -1.48 Mn |
| Sep 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 167,000.00 |
| Dec 31, 2023 | -90,000.00 |
| Sep 30, 2023 | -407,000.00 |
| Jun 30, 2023 | 383,000.00 |
| Mar 31, 2023 | 313,000.00 |
| Dec 31, 2022 | 602,000.00 |
| Sep 30, 2022 | -2.38 Mn |
| Jun 30, 2022 | -411,000.00 |
| Mar 31, 2022 | 299,000.00 |
| Dec 31, 2021 | 214,000.00 |
| Sep 30, 2021 | -128,000.00 |